Document is current
Any future updates will be listed below
-
Authors
Zhang, Xiaodi https://orcid.org/0009-0002-4433-3053
van Greevenbroek, Marleen M. J.
Scheijen, Jean L. J. M.
Eussen, Simone J. P. M.
Kelly, Jaycey
Stehouwer, Coen D. A.
Schalkwijk, Casper G.
Wouters, Kristiaan https://orcid.org/0000-0001-7127-6950
-
Funding
Funding for this research was provided by:
China Scholarship Council (China Scholarship Council)
European Regional Development Fund (European Regional Development Fund)
ZonMw (849200001)
- License Information
-
More Information
Article History
Received: 16 August 2024
Accepted: 12 January 2025
First Online: 23 January 2025
Declarations
:
: The authors declare that they have no conflict of interest.
: XZ was supported by the China Scholarship Council. The Maastricht Study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 31O.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), the Cardiovascular Center (CVC, Maastricht, the Netherlands), School for Mental Health and Neuroscience (MHeNS, Maastricht, The Netherlands), Cardiovascular Research Institute Maastricht (CARIM, Maastricht, the Netherlands), School for Public Health and Primary Care (CAPHRI, Maastricht, the Netherlands), School for Nutrition, Toxicology and Metabolism (NUTRIM, Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands).
: The study has been approved by the institutional medical ethics committee (NL31329.068.10) and the Dutch Ministry of Health, Welfare, and Sports of the Netherlands (permit 131088-105234-PG).
: All participants gave written informed consent.
